13 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Discovery of a Selective Phosphoinositide-3-Kinase (PI3K)-¿ Inhibitor (IPI-549) as an Immuno-Oncology Clinical Candidate.
Infinity Pharmaceuticals
Synthetic silvestrol analogues as potent and selective protein synthesis inhibitors.
Infinity Pharmaceuticals
Design, synthesis, and biological evaluation of hydroquinone derivatives of 17-amino-17-demethoxygeldanamycin as potent, water-soluble inhibitors of Hsp90.
Infinity Pharmaceuticals
Discovery of a potent and orally active hedgehog pathway antagonist (IPI-926).
Infinity Pharmaceuticals
Diversity-oriented synthesis of a cytisine-inspired pyridone library leading to the discovery of novel inhibitors of Bcl-2.
Infinity Pharmaceuticals
DNA-encoded chemistry technology yields expedient access to SARS-CoV-2 M
Baylor College of Medicine